UB Paderborn / Katalog / Suche / in CDI

Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union

Stem cells translational medicine, 2018-01, Vol.7 (1), p.146-154

2018

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation?

PloS one, 2015-03, Vol.10 (3), p.e0119751-e0119751

2015

Link zum Volltext

Verfügbarkeit prüfen

Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis

Molecular genetics and metabolism, 2018-06, Vol.124 (2), p.152-160

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects

PloS one, 2017-08, Vol.12 (8), p.e0182559-e0182559

2017

Link zum Volltext

Verfügbarkeit prüfen

Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects

PloS one, 2019-01, Vol.14 (1), p.e0211394-e0211394

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3

Circulation. Cardiovascular genetics, 2012-02, Vol.5 (1), p.42

2012

Link zum Volltext

Verfügbarkeit prüfen

Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects

Food & function, 2012-11, Vol.3 (11), p.1144-1152

2012

Link zum Volltext

Verfügbarkeit prüfen

Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial

Diabetes care, 2013-09, Vol.36 (9), p.2566-2572

2013

Link zum Volltext

Verfügbarkeit prüfen

A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions

Diabetes technology & therapeutics, 2013-08, Vol.15 (8), p.634

2013

Link zum Volltext

Verfügbarkeit prüfen

Dietary glycemic index and liver steatosis

The American journal of clinical nutrition, 2006-07, Vol.84 (1), p.136-142

2006

Link zum Volltext

Verfügbarkeit prüfen

Dietary antioxidants and glucose metabolism

Current opinion in clinical nutrition and metabolic care, 2008-07, Vol.11 (4), p.471-476

2008

Link zum Volltext

Verfügbarkeit prüfen

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

Clinical and translational science, 2018-01, Vol.11 (1), p.21-27

2018

Link zum Volltext

Verfügbarkeit prüfen

Addressing challenges in the diagnosis and treatment of rare genetic diseases

Nature reviews. Drug discovery, 2018-03, Vol.17 (3), p.151-152

2018

Link zum Volltext

Verfügbarkeit prüfen

Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress

The American journal of clinical nutrition, 2008-05, Vol.87 (5), p.1290-1297

2008

Link zum Volltext

Verfügbarkeit prüfen

Multivariate Prediction of Subcutaneous Glucose Concentration in Type 1 Diabetes Patients Based on Support Vector Regression

IEEE journal of biomedical and health informatics, 2013-01, Vol.17 (1), p.71-81

2013

Link zum Volltext
IEEE_Xplore

Clinically driven semi-supervised class discovery in gene expression data

Bioinformatics, 2008-08, Vol.24 (16), p.i90-i97

2008

Link zum Volltext

Verfügbarkeit prüfen

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force

Orphanet journal of rare diseases, 2019-10, Vol.14 (1), p.225-225, Article 225

2019

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study

European journal of preventive cardiology, 2014-04, Vol.21 (4), p.456-463

2014

Link zum Volltext

Verfügbarkeit prüfen

Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects

British journal of nutrition, 2005-05, Vol.93 (5), p.619-625

2005

Link zum Volltext

Verfügbarkeit prüfen

Challenges and opportunities in neurometabolic disease treatment with enzyme delivery

Expert opinion on drug delivery, 2024-07, p.1-12

2024

Link zum Volltext

Verfügbarkeit prüfen

The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis

Atherosclerosis, 2010-01, Vol.208 (1), p.240-245

2010

Link zum Volltext

Verfügbarkeit prüfen

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis

Journal of inborn errors of metabolism and screening, 2018-09, Vol.6

2018

Link zum Volltext

Verfügbarkeit prüfen

Boosting delivery of rare disease therapies: the IRDiRC Orphan Drug Development Guidebook

Nature reviews. Drug discovery, 2020-08, Vol.19 (8), p.495-496

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial

Journal of inherited metabolic disease, 2018-12, Vol.41 (6), p.1215-1223

2018

Link zum Volltext

Verfügbarkeit prüfen

How to START? Four pillars to optimally begin your orphan drug development

Orphanet journal of rare diseases, 2023-08, Vol.18 (1), p.229-229, Article 229

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union

Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation?

Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects

Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3

Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects

Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial

A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions

Dietary glycemic index and liver steatosis

Dietary antioxidants and glucose metabolism

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

Addressing challenges in the diagnosis and treatment of rare genetic diseases

Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress

Multivariate Prediction of Subcutaneous Glucose Concentration in Type 1 Diabetes Patients Based on Support Vector Regression

Clinically driven semi-supervised class discovery in gene expression data

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force

Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study

Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects

Challenges and opportunities in neurometabolic disease treatment with enzyme delivery

The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis

Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis

Boosting delivery of rare disease therapies: the IRDiRC Orphan Drug Development Guidebook

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial

How to START? Four pillars to optimally begin your orphan drug development

Suchergebnisse filtern